NASDAQ: EXAS 17.38
Change: +0.06 +0.35% Minimum 20 min delay
3:59 PM ET on Jul 29, 2016
Volume: 4,512,659

OUR FIRST MISSION:

To work with patients, payers & providers to help play a role in the eradication of colorectal cancer.

Exact Sciences Laboratories

How our lab’s technologies and efficiencies carry Cologuard from arrival to result.

The Exact Science of Customer Care

Supporting patients and driving compliance is a science all its own. Learn how we practice it.

Tennis Anyone?

How Cologuard's keeping Steve Rubin on the court and bringing physicians into play.

Latest Financial Reports

Current Corporate Presentation

Corporate Presentation - August 2016 July 26, 2016
Download (PDF 7.69 MB)